A Phase II NCCTG study of irinotecan and docetaxel in previously treated patients with non-small cell lung cancer.
Molina JR, Nikcevich D, Hillman S, Geyer S, Drevyanko T, Jett J, Verdirame J, Tazelaar H, Rowland K, Wos E, Kutteh L, Nair S, Fitch T, Flynn P, Stella P, Adjei AA.
Molina JR, et al. Among authors: hillman s.
Cancer Invest. 2006 Jun-Jul;24(4):382-9. doi: 10.1080/07357900600705318.
Cancer Invest. 2006.
PMID: 16777690
Clinical Trial.